Hospital-Based Program for Treatment of Severe Cardiopulmonary Disease With Inhaled Nitric Oxide
Status:
Terminated
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this program is to evaluate the logistic issues and patient requirements for
chronic pulsed INOmax delivery in ambulatory, home-care patients. To understand patient
needs, patients with a variety of underlying diseases will be included. Safety of chronic
therapy will be monitored by serial measurements of methemoglobin, platelet function assay
and reported adverse events.